New hope for kidney disease: drug slows decline in chinese patients
NCT ID NCT06610526
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study tests the drug dapagliflozin in 731 Chinese adults with chronic kidney disease to see if it can slow kidney function decline and reduce complications. Participants take the drug alongside their current treatments. The goal is to gather safety and effectiveness data for this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100034, China
-
Research Site
Beijing, 100044, China
-
Research Site
Beijing, 100068, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 102206, China
-
Research Site
Changchun, 130021, China
-
Research Site
Dongguan, 523059, China
-
Research Site
Foshan, 528308, China
-
Research Site
Fuyang, 236012, China
-
Research Site
Fuzhou, 350001, China
-
Research Site
Ganzhou, 341099, China
-
Research Site
Harbin, 150000, China
-
Research Site
Hefei, 230601, China
-
Research Site
Hengyang, 421001, China
-
Research Site
Huaian, 223399, China
-
Research Site
Huizhou, 516001, China
-
Research Site
Jilin, 132011, China
-
Research Site
Jinan, 250014, China
-
Research Site
Jining, 272029, China
-
Research Site
Lanzhou, 730000, China
-
Research Site
Linyi, 276199, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanjing, 210029, China
-
Research Site
Nanning, 530021, China
-
Research Site
Ningbo, 315010, China
-
Research Site
Shanghai, 200090, China
-
Research Site
Shenzhen, 518036, China
-
Research Site
Suzhou, 215004, China
-
Research Site
Taian, 271099, China
-
Research Site
Tianjin, 300121, China
-
Research Site
Wuhu, 241000, China
-
Research Site
Wuxi, 214023, China
-
Research Site
Xi'an, 710000, China
-
Research Site
Xiamen, 361004, China
Conditions
Explore the condition pages connected to this study.